无法切除的肝细胞癌的系统疗法:当前的景观和未来的方向
Zachary Philippi1, Keerthi D Reddy1, Sheza Malik2
1Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
International journal of molecular sciences
|July 12, 2025
概括
肝细胞癌 (HCC) 治疗在免疫疗法和向性药物方面取得了进展. 考虑到瘤生物学和患者因素的个性化方法对于改善这种常见肝癌的结果至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 医学瘤学 医学瘤学
- 癌症研究 癌症研究
背景情况:
- 肝细胞癌 (HCC) 是一种主要的肝癌,也是癌症死亡的主要原因.
- 由于无症状的进展,晚期诊断很常见,往往会使治疗复杂化,因为潜在的肝硬化.
- 2007年Sorafenib的批准是一个里程碑,但治疗场景自那时起发生了重大变化.
研究的目的:
- 审查目前肝细胞癌 (HCC) 的全身治疗选择.
- 探索新兴策略,包括新型免疫疗法和向药物.
- 强调需要在HCC管理中采用个性化治疗方法.
主要方法:
- 这是对HCC目前和新兴系统性疗法的叙述性综述.
- 该综述综合了第一线,后续线和新型治疗策略的信息.
- 它考虑了诸如瘤生物学,肝功能和患者表现状况等因素.
主要成果:
- 组合疗法如阿特佐利祖马布加贝瓦齐祖马布显示出优异的结果,是标准的第一线选择.
- 显著的进展包括免疫检查点抑制剂和抗血管生成剂.
- 将分子洞察力转化为个性化的HCC治疗仍然是一个挑战.
结论:
- 目前的HCC系统治疗包括既有和新型免疫疗法和向药物.
- 个性化治疗计划对于优化HCC患者的治疗结果至关重要.
- 未来的研究应该专注于个性化医学和HCC的新治疗策略.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.0K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
609
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
